Free Trial

Charles River Laboratories International (CRL) Competitors

Charles River Laboratories International logo
$185.77 +3.62 (+1.99%)
(As of 12/20/2024 05:45 PM ET)

CRL vs. MTD, ILMN, WAT, TECH, BIO, BRKR, PACB, HBIO, TMO, and A

Should you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Mettler-Toledo International (MTD), Illumina (ILMN), Waters (WAT), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry.

Charles River Laboratories International vs.

Mettler-Toledo International (NYSE:MTD) and Charles River Laboratories International (NYSE:CRL) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, community ranking, risk, institutional ownership, earnings and analyst recommendations.

Mettler-Toledo International has higher earnings, but lower revenue than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mettler-Toledo International$3.79B6.85$788.78M$37.0933.18
Charles River Laboratories International$4.06B2.34$474.62M$7.9923.25

95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are held by institutional investors. 1.9% of Mettler-Toledo International shares are held by insiders. Comparatively, 1.3% of Charles River Laboratories International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Mettler-Toledo International presently has a consensus target price of $1,351.25, indicating a potential upside of 9.79%. Charles River Laboratories International has a consensus target price of $214.00, indicating a potential upside of 15.20%. Given Charles River Laboratories International's higher possible upside, analysts plainly believe Charles River Laboratories International is more favorable than Mettler-Toledo International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mettler-Toledo International
1 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Charles River Laboratories International
3 Sell rating(s)
10 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.93

In the previous week, Mettler-Toledo International had 1 more articles in the media than Charles River Laboratories International. MarketBeat recorded 8 mentions for Mettler-Toledo International and 7 mentions for Charles River Laboratories International. Mettler-Toledo International's average media sentiment score of 1.03 beat Charles River Laboratories International's score of 0.77 indicating that Mettler-Toledo International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mettler-Toledo International
2 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Charles River Laboratories International
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Mettler-Toledo International has a net margin of 21.15% compared to Charles River Laboratories International's net margin of 10.44%. Charles River Laboratories International's return on equity of 14.29% beat Mettler-Toledo International's return on equity.

Company Net Margins Return on Equity Return on Assets
Mettler-Toledo International21.15% -531.78% 24.79%
Charles River Laboratories International 10.44%14.29%6.53%

Charles River Laboratories International received 122 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 60.25% of users gave Charles River Laboratories International an outperform vote while only 56.68% of users gave Mettler-Toledo International an outperform vote.

CompanyUnderperformOutperform
Mettler-Toledo InternationalOutperform Votes
369
56.68%
Underperform Votes
282
43.32%
Charles River Laboratories InternationalOutperform Votes
491
60.25%
Underperform Votes
324
39.75%

Mettler-Toledo International has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, Charles River Laboratories International has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500.

Summary

Mettler-Toledo International beats Charles River Laboratories International on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRL vs. The Competition

MetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE Exchange
Market Cap$9.50B$4.20B$5.13B$19.18B
Dividend YieldN/A1.78%5.08%3.61%
P/E Ratio23.2555.3489.5841.30
Price / Sales2.3447.521,116.1217.58
Price / Cash11.5223.6242.8221.28
Price / Book2.653.144.775.32
Net Income$474.62M$139.50M$120.15M$989.88M
7 Day Performance-2.46%-0.35%-1.92%-3.54%
1 Month Performance-4.42%3.18%11.47%-3.68%
1 Year Performance-21.19%14.18%30.54%12.14%

Charles River Laboratories International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRL
Charles River Laboratories International
4.5242 of 5 stars
$185.77
+2.0%
$214.00
+15.2%
-19.8%$9.50B$4.06B23.2521,800
MTD
Mettler-Toledo International
3.9541 of 5 stars
$1,268.03
-0.7%
$1,351.25
+6.6%
+3.7%$26.76B$3.76B34.4317,300Positive News
ILMN
Illumina
4.4832 of 5 stars
$143.72
-0.1%
$165.95
+15.5%
-0.6%$22.79B$4.39B-14.449,300
WAT
Waters
3.7199 of 5 stars
$375.89
-0.6%
$375.85
0.0%
+13.9%$22.32B$2.91B36.097,900
TECH
Bio-Techne
4.6346 of 5 stars
$76.36
+0.9%
$82.00
+7.4%
-3.5%$12.13B$1.17B81.073,100
BIO
Bio-Rad Laboratories
4.3519 of 5 stars
$339.77
+1.0%
$394.20
+16.0%
+6.2%$9.51B$2.58B-12.308,030Analyst Revision
Positive News
BRKR
Bruker
4.9904 of 5 stars
$57.44
-0.5%
$74.70
+30.0%
-21.7%$8.71B$2.96B27.759,707Analyst Forecast
PACB
Pacific Biosciences of California
1.5488 of 5 stars
$2.05
+4.6%
$2.95
+44.1%
-79.8%$561.41M$200.52M-1.46730
HBIO
Harvard Bioscience
1.2851 of 5 stars
$2.12
-1.9%
N/A-57.8%$92.47M$97.73M-6.55490
TMO
Thermo Fisher Scientific
4.766 of 5 stars
$532.06
+1.0%
$652.30
+22.6%
+0.9%$203.51B$42.86B33.03122,000
A
Agilent Technologies
4.7188 of 5 stars
$137.75
-0.9%
$143.62
+4.3%
-2.7%$39.58B$6.51B31.4518,100Analyst Forecast
Analyst Revision

Related Companies and Tools


This page (NYSE:CRL) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners